TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza
Research on influenza detailed by M.R. Siddiqui and co-authors
March 25th, 2008
"A decision analytical model was developed to investigate the cost-effectiveness of stockpiling antiviral (AV) drugs for a potential influenza pandemic in the United Kingdom and the possible role of near-patient testing in conserving AV drug stocks," scientists writing in the journal Emerging Infectious Diseases report. "Under base-case assumptions (including a fixed stockpile that was smaller than the clinical attack rate), the treat-only option (treating all symptomatic patients with AV drugs) would be considered cost-effective (1,900- pound 13,700 pound per quality-adjusted life year [QALY] gained, depending on the fatality scenario), compared with no...
Source: TB & Outbreaks Week (2008-03-25)
|
